English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/55105
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

A study on partially biodegradable microparticles as carriers of active glycolipids

AuthorsLópez-Donaire, M. L. ; Fernández-Gutiérrez, M.; Parra-Cáceres, J.; Vázquez Lasa, Blanca; García-Álvarez, I.; Fernández-Mayoralas, Alfonso ; San Román, Julio
KeywordsComposite microparticles
Delivery system
Glycolipid
Anti-tumor drugs
Issue Date2010
PublisherElsevier
CitationActa Biomaterialia 6 : 1360–1369 (2010)
AbstractThis paper describes a study on the preparation and characterisation of partially biodegradable microparticles of poly(e-caprolactone)/poly(ethyl methacrylate) (PCL/PEMA) as carriers of synthetic glycolipids with antimitotic activity against brain tumour cells. Microparticles prepared by suspension polymerisation of methacrylate in the presence of already polymerised PCL showed a predominantly spherical but complex morphology, with segregation of PCL micro/nano-domains towards the surface. Small diameter discs were prepared by compression moulding of blends of microparticles and the active principle under mild conditions. The in vitro behaviour of the discs and release of the glycolipid were studied in different simulated fluid models. Ingress of fluids increased with increasing hydrophobicity of the medium. Release of the glycolipid was sustained in all fluids, the most prolonged profile being in human synovial fluid and phosphate-buffered saline modified with 20 vol.% dioxane. Slow disintegration of the discs and partial degradation of the microparticles was evident in accelerated studies. The antimitotic activity of glycolipid released from the discs was proved against a human glioblastoma line. This activity, along with selectivity against human fibroblasts, could be controlled by the amount of drug charged in the disc.
Publisher version (URL)http://dx.doi.org/10.1016/j.actbio.2009.11.009
URIhttp://hdl.handle.net/10261/55105
DOI10.1016/j.actbio.2009.11.009
ISSN1742-7061
Appears in Collections:(IQOG) Artículos
(ICTP) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.